Nature Communications (Feb 2022)
Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells
Abstract
Broadly neutralizing antibodies (bNAbs) neutralize HIV-1 and exert Fc-dependent activities against infected cells. Here, Dufloo et al. show that bNAbs also block HIV-1 release by trapping viral particles at the surface of infected cells.